Stay in Touch
Get sneak previews of special offers & upcoming events delivered to your inbox.
Sign in
04-24-2020 09:06 PM
04-24-2020 09:10 PM
Sigh. So much misinformation.
That healight gadget announcement was a paid for press release from the company regarding something that is being tested, like a kabillion other potential cures and helps. It also included this required info.
"This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. All statements other than statements of historical facts contained in this presentation, are forward-looking statements. Forward-looking statements are generally written in the future tense and/or are preceded by words such as ″may,″ ″will,″ ″should,″ ″forecast,″ ″could,″ ″expect,″ ″suggest,″ ″believe,″ ″estimate,″ ″continue,″ ″anticipate,″ ″intend,″ ″plan,″ or similar words, or the negatives of such terms or other variations on such terms or comparable terminology. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include, among others: our ability to successfully commercialize Healight Platform Technology, our ability to obtain FDA approval for the Healight Platform Technology, the effectiveness of the Healight Platform Technology in treating patients with COVID-19 or other illnesses, our ability to adequately protect the intellectual property associated with the Healight Platform Technology, regulatory delays, the reliability of the Healight Platform Technology in killing viruses and bacteria, market acceptance of UV based medical devices, risks associated with the COVID-19 Rapid Test including our ability to enforce the exclusivity provisions of the distribution agreement, the reliability of serological testing in detecting COVID-19, shipping delays and their impact on our ability to introduce the COVID-19 Rapid Test, the ability of the COVID-19 Rapid Test to accurately and reliably test for COVID-19, the manufacturer of the COVID-19 Rapid Test’s ability to manufacture such testing kits on a high volume scale, manufacturing problems or delays related to the COVID-19 Rapid Test, our ability to satisfy any labelling conditions or other FDA or other regulatory conditions to sell the COVID-19 Rapid Test Kit, the demand or lack thereof for the COVID-19 Rapid Test Kit, our ability to obtain additional COVID-19 Rapid Tests to meet demand, our ability to secure additional tests if the manufacture of the COVID-19 Rapid Tests is unable to meet demand, the effects of the business combination of Aytu and the Commercial Portfolio and the recently completed merger (“Merger”) with Innovus Pharmaceuticals, including the combined company’s future financial condition, results of operations, strategy and plans, the ability of the combined company to realize anticipated synergies in the timeframe expected or at all, changes in capital markets and the ability of the combined company to finance operations in the manner expected, the diversion of management time on Merger-related issues and integration of the Commercial Portfolio, the ultimate timing, outcome and results of integrating the operations the Commercial Portfolio and Innovus with Aytu’s existing operations, risks relating to gaining market acceptance of our products, obtaining or maintaining reimbursement by third-party payors for our prescription products, the potential future commercialization of our product candidates, the anticipated start dates, durations and completion dates, as well as the potential future results, of our ongoing and future clinical trials, the anticipated designs of our future clinical trials, anticipated future regulatory submissions and events, our anticipated future cash position and future events under our current and potential future collaboration. We also refer you to the risks described in ″Risk Factors″ in Part I, Item 1A of the company’s Annual Report on Form 10-K and in the other reports and documents we file with the Securities and Exchange Commission from time to time."
In short: don't count your heallight chickens until they've hatched. We have already been down this road with some widely promoted medicines that have turned out to be deadly or ineffective.
Would be nice for it or any of them to work. We all want something to help us. We are desperate. But let's save the champagne and public announcements and promotions for something that is fully tested and ready to use. Otherwise it's cruel false hope. And it makes people draw connections that are not so, like sunny days being extra safe so you can let down your protection and other ideas.
04-24-2020 09:35 PM
@millieshops wrote:@KrimpetteI cannot for the life of me understand the suggestion that as soon as the warm weather sets in, everything will be all better I'm not on Palm Beach where Mara-Lago is, but I'm not all that far away and we've had a few 90+ days already and the numbers still aren't all that comforting.
The heat hasn't ever meant that we were safe from the flu let alone this rogue virus.
It's possible the numbers would be even higher without those 90+ days.
04-24-2020 09:41 PM
@Porcelain wrote:Sigh. So much misinformation.
That healight gadget announcement was a paid for press release from the company regarding something that is being tested, like a kabillion other potential cures and helps. It also included this required info.
"This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, or the Exchange Act. All statements other than statements of historical facts contained in this presentation, are forward-looking statements. Forward-looking statements are generally written in the future tense and/or are preceded by words such as ″may,″ ″will,″ ″should,″ ″forecast,″ ″could,″ ″expect,″ ″suggest,″ ″believe,″ ″estimate,″ ″continue,″ ″anticipate,″ ″intend,″ ″plan,″ or similar words, or the negatives of such terms or other variations on such terms or comparable terminology. These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or results to differ materially. These risks and uncertainties include, among others: our ability to successfully commercialize Healight Platform Technology, our ability to obtain FDA approval for the Healight Platform Technology, the effectiveness of the Healight Platform Technology in treating patients with COVID-19 or other illnesses, our ability to adequately protect the intellectual property associated with the Healight Platform Technology, regulatory delays, the reliability of the Healight Platform Technology in killing viruses and bacteria, market acceptance of UV based medical devices, risks associated with the COVID-19 Rapid Test including our ability to enforce the exclusivity provisions of the distribution agreement, the reliability of serological testing in detecting COVID-19, shipping delays and their impact on our ability to introduce the COVID-19 Rapid Test, the ability of the COVID-19 Rapid Test to accurately and reliably test for COVID-19, the manufacturer of the COVID-19 Rapid Test’s ability to manufacture such testing kits on a high volume scale, manufacturing problems or delays related to the COVID-19 Rapid Test, our ability to satisfy any labelling conditions or other FDA or other regulatory conditions to sell the COVID-19 Rapid Test Kit, the demand or lack thereof for the COVID-19 Rapid Test Kit, our ability to obtain additional COVID-19 Rapid Tests to meet demand, our ability to secure additional tests if the manufacture of the COVID-19 Rapid Tests is unable to meet demand, the effects of the business combination of Aytu and the Commercial Portfolio and the recently completed merger (“Merger”) with Innovus Pharmaceuticals, including the combined company’s future financial condition, results of operations, strategy and plans, the ability of the combined company to realize anticipated synergies in the timeframe expected or at all, changes in capital markets and the ability of the combined company to finance operations in the manner expected, the diversion of management time on Merger-related issues and integration of the Commercial Portfolio, the ultimate timing, outcome and results of integrating the operations the Commercial Portfolio and Innovus with Aytu’s existing operations, risks relating to gaining market acceptance of our products, obtaining or maintaining reimbursement by third-party payors for our prescription products, the potential future commercialization of our product candidates, the anticipated start dates, durations and completion dates, as well as the potential future results, of our ongoing and future clinical trials, the anticipated designs of our future clinical trials, anticipated future regulatory submissions and events, our anticipated future cash position and future events under our current and potential future collaboration. We also refer you to the risks described in ″Risk Factors″ in Part I, Item 1A of the company’s Annual Report on Form 10-K and in the other reports and documents we file with the Securities and Exchange Commission from time to time."
In short: don't count your heallight chickens until they've hatched. We have already been down this road with some widely promoted medicines that have turned out to be deadly or ineffective.
Would be nice for it or any of them to work. We all want something to help us. We are desperate. But let's save the champagne and public announcements and promotions for something that is fully tested and ready to use. Otherwise it's cruel false hope. And it makes people draw connections that are not so, like sunny days being extra safe so you can let down your protection and other ideas.
@Porcelain, yes, a couple of companies seemed to have garnered attention, as I posted earlier.
I would bet my house on the fact that we will not be inserting UV into our bodies.And I hope to heck that no one will be drinking a bleach concoction.
These mindless gee what ifs based on press releases or those hawking a "cure" are a diversion that we really don't need right now.
04-24-2020 10:24 PM - edited 04-24-2020 10:26 PM
@Porcelain Kabillion 😊
04-25-2020 02:02 AM
@hckynut I think it is normal to be interested in the world around us. The U of Washington is not recommending opening NE until late June I think.
This is the Mayor of the city in which the Nebraska Medical Center is located. There is a reason most of the 1st patients of Ebola/SARS and this Covid Virus are sent here.
I have seen nor heard this facility "recommend" anything against the Mayor's decision about this. Nothing against Washington U, but it is not located in our City, nor was it the 1st place the above mentioned diseased patients were sent.
I will stick with our Nebraska Medical Center not saying anything negative the Mayor's decision.
hckynut 🏒
04-25-2020 04:28 AM
Everyday new story well if the heat kills it today in Az was 96 am I safe? No cuz Africa & India are hot they have the virus. Some say ultra violet rays kills it so do I leave all my grocery items in the sun for awhile? Wish we knew what kills it & how to deal with it but I will be my own Governor and protect myself. I don't think we are ready to start back but think they will do it slow. Heard this winter may get another round of it but we have no answers now hope by then we do. They are trying to figure it out but just got to wait.
04-25-2020 06:30 AM
@LTT1 .........Thank you. I have always been a straight shooter and only realized in my later life that a lot of people dont like that and become offended. I do not like inuendo's or beating around the bush when people are talking to me therefore I thought everyone was that way. So I need a lot of help in that area therefore I need God's help.
04-25-2020 07:49 AM - edited 04-25-2020 07:52 AM
Coronavirus pandemic inspires demand for UV airplane cleaner
A California company thinks it’s a perfect solution for decontaminating airplanes.
Dimer UCV Innovations created a UV-C-emitting cleaning machine called GermFalcon for the airline industry in 2014 - but it’s only with the coronavirus that demand has really taken off. “We didn’t want it to take a pandemic to create the demand in this industry. That’s the situation we’re in and we’re building our units as quickly as we can,” said Elliot Kreitenberg, president and cofounder of Dimer UCV Innovations.
GermFalcon is a food cart-sized robotic tool that is pushed down the aisle of the plane. Mechanical wings expand and emit UV-C light onto cabin surfaces. A protective barrier shields the operator from the ultraviolet light, which can be harmful. Kreitenberg said the GermFalcon can clean a typical narrow body aircraft in three minutes. UV-C can damage the nucleic acids within an organism and prevent it from replicating.
Its use as a disinfectant is fairly common in hospital and laboratory settings, experts have said. But elsewhere, such as in aviation, it is uncommon. There are three types of ultraviolet light: UV-A, UV-B and UV-C, and UV-C is the most damaging. About 95 percent of the UV radiation from the sun comes in the form of UV-A.
Organizations like CHEO Research Institute in Canada have looked at using UV-C to disinfect personal protective equipment such as N95 masks, but not surfaces.
According to University of California Santa Barbara, Seoul Semiconductor Co Ltd has been working on UV LEDs for the purpose of decontaminating surfaces. That company reported “99.9% sterilization of coronavirus in 30 seconds.”
04-25-2020 09:18 AM
From the Daily Mail you can also find it in usatoday, huffpost.
Christina C (wife of Chris C) wrote her Dr Lancaster an energy medicine and homeopathic physician suggested taking a bath with bleach. Yes bleach. She put 1/2 cup of Clorox bleach into her bath.
She posted this before it was said at the briefing. After briefing she took down post.
Her husband didn't mention this on air. Wonder why?
Get sneak previews of special offers & upcoming events delivered to your inbox.
*You're signing up to receive QVC promotional email.
Find recent orders, do a return or exchange, create a Wish List & more.
Privacy StatementGeneral Terms of Use
QVC is not responsible for the availability, content, security, policies, or practices of the above referenced third-party linked sites nor liable for statements, claims, opinions, or representations contained therein. QVC's Privacy Statement does not apply to these third-party web sites.
© 1995-2025 QVC, Inc. All rights reserved. | QVC, Q and the Q logo are registered service marks of ER Marks, Inc. 888-345-5788